Search

The Belinda Parker laboratory explores interactions in the cancer microenvironment that prevent or support tumour invasion and spread (metastasis) to other tissues, including bone. Our overall objective is to uncover new... Read more

Acquired treatment resistance, whereby patients respond well to primary treatment but eventually develop drug resistance, is common across a range of cancer types. It is particularly problematic in the most common form of ovarian... Read more

The Kara Britt lab's overall objective is to uncover new cell specific biomarkers that associate with breast cancer risk that also direct the development of novel prevention strategies. We also have numerous breast cancer... Read more

The research focuses on understanding how cells of the tumour microenvironment can contribute to the progression of cancer either by promoting resistance to existing drugs or through enhancing metastatic spread. We are using... Read more

The Ricky Johnstone lab utilises and integrates advanced genomics technologies including CRISPR-based gene editing and genome-wide sequencing analysis, state-of-the art cell and molecular biology techniques and systems and... Read more

With the recognition over the last 10 years that cancer is a genetic disease, the approach to diagnosis and classification of cancer and stratifying patients for treatment has radically changed. The use of biomarkers that define... Read more